These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3087473)

  • 41. [Acroscleroderma with Raynaud's phenomenon].
    GRIFFO V
    Athena; 1957; 23(10-12):320-1. PubMed ID: 13499164
    [No Abstract]   [Full Text] [Related]  

  • 42. Calcium influx into red blood cells: the effect of sera from patients with systemic sclerosis.
    Rademaker M; Thomas RH; Kirby JD; Kovacs IB
    Clin Exp Rheumatol; 1991; 9(3):247-51. PubMed ID: 1879084
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of ketanserin on Raynaud's phenomenon in progressive systemic sclerosis: a double-blind trial.
    Lukác J; Rovenský J; Tauchmannová H; Zitnan D
    Drugs Exp Clin Res; 1985; 11(9):659-63. PubMed ID: 3916837
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Etiological profile of secondary Raynaud's phenomenon in an internal medicine department. About 121 patients].
    Ben Salem T; Tougorti M; Bziouech S; Lamloum M; Khanfir M; Ben Ghorbel I; Houman MH
    J Med Vasc; 2018 Feb; 43(1):29-35. PubMed ID: 29425538
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effects of long-term iloprost therapy on Raynaud's phenomenon in progressive systemic sclerosis].
    Cordioli E; Virgilio S; Ghirardi R; Martinelli M
    Minerva Med; 1992 Nov; 83(11):739-44. PubMed ID: 1281297
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pathogenesis of Raynaud's phenomenon.
    Herrick AL
    Rheumatology (Oxford); 2005 May; 44(5):587-96. PubMed ID: 15741200
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of severe Raynaud's phenomenon with bosentan in a patient with systemic sclerosis.
    Dunne J; Dutz J; Shojania K; Ng B; van Eeden S
    Rheumatology (Oxford); 2006 Jul; 45(7):911-2. PubMed ID: 16531439
    [No Abstract]   [Full Text] [Related]  

  • 48. Beyond Raynaud's phenomenon hides very early systemic sclerosis: the assessment of organ involvement is always mandatory.
    Czirják L; Matucci-Cerinic M
    Rheumatology (Oxford); 2011 Feb; 50(2):250-1. PubMed ID: 21115465
    [No Abstract]   [Full Text] [Related]  

  • 49. Cutaneous microcirculation in systemic sclerosis and response to intra-arterial reserpine.
    Nilsen KH; Jayson MI
    Br Med J; 1980 Jun; 280(6229):1408-11. PubMed ID: 7427134
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of nifedipine in Raynaud's phenomenon associated with systemic sclerosis.
    Thakur SK; Gopinathan VP; Jagdish TK; Bhalla IP; Shetty KJ
    J Assoc Physicians India; 1986 Jul; 34(7):536. PubMed ID: 3759897
    [No Abstract]   [Full Text] [Related]  

  • 51. [Analysis of Raynaud's phenomenon in systemic scleroderma: comparative study with that in vibration disease].
    Maeda M; Shikano Y; Mori S
    Nihon Hifuka Gakkai Zasshi; 1989 Nov; 99(12):1255-9. PubMed ID: 2622060
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acute estrogen administration can reverse cold-induced coronary Raynaud's phenomenon in systemic sclerosis.
    Lekakis J; Mavrikakis M; Emmanuel M; Prassopoulos V; Papamichael C; Moulopoulou D; Ziaga A; Kostamis P; Moulopoulos S
    Clin Exp Rheumatol; 1996; 14(4):421-4. PubMed ID: 8871843
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical implications from capillaroscopic analysis in patients with Raynaud's phenomenon and systemic sclerosis.
    Herrick AL; Cutolo M
    Arthritis Rheum; 2010 Sep; 62(9):2595-604. PubMed ID: 20506306
    [No Abstract]   [Full Text] [Related]  

  • 54. Short-term effect of cold provocation on single-breath carbon monoxide diffusing capacity in subjects with and without Raynaud's phenomenon.
    Gastaud M; Dolisi C; Bermon S; Gaudin P; Defauw G; Ardisson JL
    Clin Exp Rheumatol; 1995; 13(5):617-21. PubMed ID: 8575140
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Systemic sclerosis: bilateral improvement of Raynaud's phenomenon with unilateral digital sympathectomy.
    Wasserman A; Brahn E
    Semin Arthritis Rheum; 2010 Oct; 40(2):137-46. PubMed ID: 19878974
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Esophageal motility, systemic scleroderma and Raynaud's phenomenon].
    Gosselin A
    Gastroenterol Clin Biol; 1985 Feb; 9(2):127-9. PubMed ID: 3979733
    [No Abstract]   [Full Text] [Related]  

  • 57. Reproducibility of cold provocation in patients with Raynaud's phenomenon.
    Wigley FM; Malamet R; Wise RA
    J Rheumatol; 1987 Aug; 14(4):751-5. PubMed ID: 3668980
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Raynaud's phenomenon and systemic scleroderma].
    Fiessinger JN; Housset E
    Rev Prat; 1975 May; 25(25):1989-92, 1997-8. PubMed ID: 1135587
    [No Abstract]   [Full Text] [Related]  

  • 59. [Rheology of giant capillary occlusion in secondary Raynaud's phenomenon within the scope of systemic sclerosis].
    Schmid-Schönbein H; Goebel W; Perkkiö J; Polster H; Jacobs M; Lemmens HA
    Vasa Suppl; 1989; 27():61-3. PubMed ID: 2623545
    [No Abstract]   [Full Text] [Related]  

  • 60. In systemic sclerosis patients the anxiety disorder and Raynaud's phenomenon are increased during lock down period for COVID-19 pandemic.
    Gigante A; Villa A; Pellicano C; Rosato E
    Intern Emerg Med; 2021 Jun; 16(4):1095-1096. PubMed ID: 33175296
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.